U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Inactive Ingredients in Approved Drug Products Search

Inactive Ingredient Search for Approved Drug Products

You are Searching: Change and Deletion by Inactive Ingredient Name Beginning with B

Quarter Inactive Ingredient Route of Administration Dosage Form Maximum Potency per unit dose Maximum Daily Exposure Status
138001 Q2 2022 BETADEX TOPICAL GEL 20mg Correction
138002 Q3 2022 BETADEX TOPICAL GEL 1.00 %w/w Correction
138003 Q2 2022 BUTYL ALCOHOL ORAL TABLET, EXTENDED RELEASE 0.02 mg Correction
138004 Q3 2022 BUTYL ALCOHOL ORAL TABLET, EXTENDED RELEASE NA Correction
138088 Q3 2022 BETADEX SULFOBUTYL ETHER SODIUM SUBCUTANEOUS INJECTION, SOLUTION 40.00 %w/v Deletion
138175 Q2 2022 BENZYL ALCOHOL INTRAVENOUS INJECTION, SOLUTION 180.00 mg MDE Replacement
138176 Q3 2022 BENZYL ALCOHOL INTRAVENOUS INJECTION, SOLUTION 400mg MDE Replacement
138177 Q2 2022 BETADEX SULFOBUTYL ETHER SODIUM INTRAVENOUS INJECTION, SOLUTION 40.00 %w/v MDE Replacement
138178 Q3 2022 BETADEX SULFOBUTYL ETHER SODIUM INTRAVENOUS INJECTION, SOLUTION 13333mg MDE Replacement
138179 Q2 2022 BLACK CURRANT ORAL SOLUTION 35.55 mg/ 5.00 ml MDE Replacement
138180 Q3 2022 BLACK CURRANT ORAL SOLUTION 213mg MDE Replacement
138181 Q2 2022 BUTYLATED HYDROXYTOLUENE TOPICAL GEL 0.10 %w/w MDE Replacement
138182 Q3 2022 BUTYLATED HYDROXYTOLUENE TOPICAL GEL 8mg MDE Replacement

 

 

FDA/Center for Drug Evaluation and Research
Office of Pharmaceutical Quality
Office of Policy for Pharmaceutical Quality
Mailbox for IID corrections IIDUpdate@fda.hhs.gov
Update Frequency: Quarterly

Data Through: July 1, 2022
Database Last Updated: July 18, 2022

Back to Top